Teampact ventures
VC Fund
Paris, France
Teampact ventures is a VC fund in Paris focused on Health Care and Artificial Intelligence. We invest in changemakers. Mission-driven startups in Climate and Health and support them with a toolbox inspired from top-level sports.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 12%
Last updated:
For AI agents: llms.txt
Industries Teampact ventures invests in
Stages Teampact ventures invests in
Countries Teampact ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Seed
- $1.5M–$5.7M
- Series A
- $5M–$23M
Investment Focus
Industry
- Health Care 6 (18%)
- Artificial Intelligence 5 (15%)
- Biotechnology 4 (12%)
- Software 3 (9%)
- Sports 2 (6%)
Stage
- Seed 12 (36%)
- Series A 6 (18%)
- Funding Round 3 (9%)
- Pre-Seed 2 (6%)
- Series B 1 (3%)
Country
- France 15 (45%)
- United Kingdom 3 (9%)
- Germany 2 (6%)
- United States 2 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Basile Agay
Partner
|
Partner | Total investments: 4 | Find email | |
Benjamin Kayser
Partner
|
Partner | Total investments: 3 | Find email | |
Romain Vidal
Partner
|
Partner | Total investments: 18 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
SquareMind
|
Come build the future of healthcare with us. | $18M / Seed / Apr 28, 2026 | |
neuroClues
|
PCUBE-LAB are developing NeuroClues, a solution to instantaneously quantify your clinical exam based on a portable laboratory using eye tracking. | $11.5M / Series A / Apr 06, 2026 | |
Generare
|
Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria. | $23.1M / Series A / Apr 02, 2026 | |
Genomines
|
World resources are expected to be depleted in the next 30 to 50 years and increasing scarcity is driving metal prices up, sometimes doubling in a few years. 86% of ore that is being extracted, containing up to 10years+ metal consumption, is not processed as metal concentration is too low. Each year a volume of low-metal concentrated soilsequivalent to the area of Paris and 100m high is extracted and not processed. It is not only a missed opportunity to recover significant amounts of metal, but it is also a serious risk for the environment. At Genomines, we bring together 2 worlds: Agriculture and Mining. We offer a sustainable alternative to conventional mining by genetically enhancing the natural ability of plants to hyperaccumulate metals. | $45M / Series A / Sep 17, 2025 | |
RainPath
|
RainPath AI leverages advanced artificial intelligence to perform virtual staining of biopsy tissue slides, a cutting-edge technology that digitally replicates traditional chemical staining used in pathology without physically applying dyes. This process transforms unstained tissue images into highly detailed, colorized images that mimicconventional histological stains like hematoxylin and eosin (H&E), enabling pathologists to analyze tissue morphology rapidly and accurately. | $3M / Seed / Jul 01, 2025 | |
Wandercraft
|
Wandercraft develops autonomous walking exoskeletons and robotic systems designed to restore upright mobility to individuals with walking impairments. The company offers devices such as Atalante X, a hands‑free, self‑balancing exoskeleton used in rehabilitation centers, and a Personal Exoskeleton prototype that leverages AI‑driven balance tosupport walking in daily life. Their systems incorporate real‑time adaptive gait algorithms and powered joints to facilitate multidirectional movement and support early intensive rehabilitation. Wandercraft collaborates with healthcare institutions and has initiated clinical trials to evaluate safety and effectiveness in managing spinal cord injuries and stroke rehabilitation. | $75M / Series D / Jun 06, 2025 | |
Le Fourgon
|
Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day. | $5.9M / Series A / Jan 30, 2025 | |
GROWL
|
Connected fitness startup transforming the boxing bag into a personal, at-home boxing & fitness coach. | $4.8M / Seed / Dec 04, 2024 | |
|
Beyond Aero
|
Beyond Aero is a Toulouse-based aerospace company founded in 2020 | $20M / Series A / Oct 25, 2024 | |
|
Generare
|
Generare is a biotech startup that discovers next-generation medicines and high-value molecules hiding in soil bacteria. | $5.5M / Seed / Oct 07, 2024 | |
| See all 33 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Teampact ventures invest in?
Teampact ventures invests primarily in Health Care, Artificial Intelligence and Biotechnology startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Teampact ventures's check size?
Teampact ventures typically joins rounds of $1.5M–$5.7M at Seed and $5M–$23M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Teampact ventures participates in.
How do I contact Teampact ventures?
Public channels for Teampact ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Teampact ventures?
The team at Teampact ventures includes Basile Agay (Partner), Benjamin Kayser (Partner) and Romain Vidal (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
